Stock KILITCH KILITCH DRUGS (INDIA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Kilitch Drugs (India) Limited

Equities

KILITCH

INE729D01010

Delayed Bombay S.E.
Other stock markets
 09:22:40 27/06/2024 BST 		5-day change 1st Jan Change
344 INR +0.01% Intraday chart for Kilitch Drugs (India) Limited +3.97% -7.46%
05-27 Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
02-26 Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia
MT
Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals
CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Kilitch Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Kilitch Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Kilitch Drugs Limited Announces Management Changes
CI
Kilitch Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Kilitch Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
Bhavin Mehta completed the acquisition of 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.
CI
Kilitch Drugs India : Resignation
PU
Kilitch Drugs Limited Announces Resignation of Princy Asati as Company Secretary & Compliance Officer
CI
Bhavin Mehta agreed to acquire 7.13% of stake in Kilitch Drugs Limited from Mukund Mehta.
CI
Kilitch Drugs Limited Commences New Facility Expansion Plan
CI
Kilitch Drugs (India) to Build Pharma Complex in Khopoli, India
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KILITCH Stock
  4. News Kilitch Drugs (India) Limited